カテゴリー： 世界, 医療/バイオ, Grand View Research

近接照射療法の世界市場2023-2030：市場規模、シェア、動向分析

【英語タイトル】Brachytherapy Market Size, Share & Trends Analysis Report By Dosage Type, By Product (Seeds, Electronic Brachytherapy), By Application (Prostate Cancer, Breast Cancer), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23OCT057）・商品コード：GRV23OCT057
・発行会社（調査会社）：Grand View Research
・発行日：2023年8月
・ページ数：150
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

近接照射療法市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の近接照射療法市場規模は2030年までに16億2000万米ドルに達し、2023年から2030年までのCAGRは7.1%で成長する見込みです。同市場の成長は、癌の有病率の上昇、技術の進歩、大手企業による研究開発投資の増加によるところが大きいです。

米国癌協会によると、米国では癌が原因で609,360人が死亡し、2022年には推定190万人の新規症例が記録されました。これは2030年までに2,460万人に増加すると予想されています。これが市場の成長を促す大きな要因になると予想されます。さらに、技術の進歩や、特に先進国における有利な償還シナリオが、市場の成長を促進すると予想されます。

近接照射療法業界で事業を展開している主な企業には、ELEKTA AB社、Varian Medical Systems社、C.R. BARD社、Eckert & Ziegler BEBIG S.A.社、IsoRay Medical社などがあります。エレクタは、乳がん、直腸がん、前立腺がん、皮膚がん、体表がん、婦人科がんなどに対して、標的を絞った精密な治療を提供しています。Flexitronは、治療を正確かつ効果的に行います。

MicroSelectronは複数の近接照射療法に使用されるシステムで、Flexitronの前身です。エステヤは皮膚がん治療に使用される電子近接照射療法です。Veneziaは、婦人科の近接照射療法に使用されるアプリケータです。さらに2020年11月、エレクタは1つの部屋で完結する画像誘導下近接照射療法のワークフローであるElekta Studioを発表しました。これにより、治療効率と患者の快適性が向上します。

新製品の発売やM&Aは、市場シェアを獲得するためにプレーヤーが採用した主要な戦略の一部です。例えば、2022年7月、BEBIG Medical社はWolf-Medizintechnik GmbH社（以下「WOmed社」）の買収に成功し、がん治療の放射線治療分野での製品提供を拡大しました。

2020年1月、米国FDAがステージIの脳腫瘍患者に対するガンマタイル治療を承認しました。イソレイとGTメディカルテクノロジー社は、ガンマタイル治療を共同開発しました。イソレイ社によると、この治療法は脳の治療に特化した唯一の放射線治療法です。今後数年間に市場各社がこのような製品を発売することで、成長が加速する見込みです。

近接照射療法市場レポートハイライト

- アプリケータ＆アフターローダ分野が近接照射療法業界を支配し、2022年には44.5%の最大収益シェアを獲得しました。アプリケータは他よりも効果的で、最小限の侵入で済むため、患者の嗜好性が高いです。

- 前立腺がん分野は、2022年に32.91%の最大の収益シェアを占めました。前立腺がんの治療における内部放射線療法の有望な応用が、このセグメントの優位性の主な要因です。

- HDR近接照射療法分野は、2022年に71.5%の最大収益シェアを占めました。処置時間の短さ、放射線被ばくからの保護、より高い有効性など、HDR内部放射線療法のさまざまな利点が、このセグメントの優位性の主な要因です。

- アジア太平洋地域は、中国とインドの新興経済圏に未開拓のビジネスチャンスが存在するため、予測期間中に最も速いCAGRで成長すると予測されています。

第1章. 方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 近接照射療法市場：投与タイプ別予測・動向分析
第5章. 近接照射療法市場：製品別予測・動向分析
第6章. 近接照射療法市場：用途別予測・動向分析
第7章. 近接照射療法市場：地域別予測・動向分析
第8章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Dosage Type
1.1.1.2. Product
1.1.1.3. Application
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Dosage Type outlook
2.2.2. Product outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Brachytherapy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Industry Value Chain Analysis
3.2.1. Reimbursement framework
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. The increasing prevalence of cancer
3.3.1.2. Technological advancements
3.3.2. Market restraint analysis
3.3.2.1. Lack of skilled radiotherapy professionals
3.4. Brachytherapy Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.4.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Brachytherapy: Dosage Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. High-Dose Rate (HDR)
4.1.2. Low-Dose Rate (LDR)
4.2. Dosage Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Brachytherapy Market by Dosage Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. High-Dose Rate (HDR)
4.5.1.1. HDR market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Low-Dose Rate (LDR)
4.5.2.1. LDR market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Brachytherapy: Product Estimates & Trend Analysis
5.1. Product Market Share, 2022 & 2030
5.2. Segment Dashboard
5.3. Global Brachytherapy Market by Material Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Seeds
5.4.1.1. Seeds market estimates and forecast 2018 to 2030 (USD Million)
5.4.2. Applicators & Afterloaders
5.4.2.1. Applicators & Afterloaders market estimates and forecast 2018 to 2030 (USD Million)
5.4.3. Electronic brachytherapy
5.4.3.1. Electronic brachytherapy market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Brachytherapy: Application Estimates & Trend Analysis
6.1. Application Market Share, 2022 & 2030
6.2. Segment Dashboard
6.3. Global Brachytherapy Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Prostrate
6.4.1.1. Prostrate market estimates and forecast 2018 to 2030 (USD Million)
6.4.2. Gynecological Cancer
6.4.2.1. Gynecological Cancer market estimates and forecast 2018 to 2030 (USD Million)
6.4.3. Breast
6.4.3.1. Breast management market estimates and forecast 2018 to 2030 (USD Million)
6.4.4. Others
6.4.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Brachytherapy Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2021
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. SWOT Analysis
7.7.2. North America Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.7.3. U.S.
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Competitive Scenario
7.7.3.4. Regulatory Framework
7.7.3.5. U.S. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.7.4. Canada
7.7.4.1. Key Country Dynamics
7.7.4.2. Target Disease Prevalence
7.7.4.3. Competitive Scenario
7.7.4.4. Regulatory Framework
7.7.4.5. Canada Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8. Europe
7.8.1. SWOT Analysis
7.8.2. Europe Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.3. UK
7.8.3.1. Key Country Dynamics
7.8.3.2. Target Disease Prevalence
7.8.3.3. Competitive Scenario
7.8.3.4. Regulatory Framework
7.8.3.5. UK Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.4. Germany
7.8.4.1. Key Country Dynamics
7.8.4.2. Target Disease Prevalence
7.8.4.3. Competitive Scenario
7.8.4.4. Regulatory Framework
7.8.4.5. Germany Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.5. France
7.8.5.1. Key Country Dynamics
7.8.5.2. Target Disease Prevalence
7.8.5.3. Competitive Scenario
7.8.5.4. Regulatory Framework
7.8.5.5. France Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.6. Italy
7.8.6.1. Key Country Dynamics
7.8.6.2. Target Disease Prevalence
7.8.6.3. Competitive Scenario
7.8.6.4. Regulatory Framework
7.8.6.5. Italy Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.7. Spain
7.8.7.1. Key Country Dynamics
7.8.7.2. Target Disease Prevalence
7.8.7.3. Competitive Scenario
7.8.7.4. Regulatory Framework
7.8.7.5. Spain Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.8. Denmark
7.8.8.1. Key Country Dynamics
7.8.8.2. Target Disease Prevalence
7.8.8.3. Competitive Scenario
7.8.8.4. Regulatory Framework
7.8.8.5. Denmark Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.9. Sweden
7.8.9.1. Key Country Dynamics
7.8.9.2. Target Disease Prevalence
7.8.9.3. Competitive Scenario
7.8.9.4. Regulatory Framework
7.8.9.5. Sweden Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.8.10. Norway
7.8.10.1. Key Country Dynamics
7.8.10.2. Target Disease Prevalence
7.8.10.3. Competitive Scenario
7.8.10.4. Regulatory Framework
7.8.10.5. Norway Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. SWOT Analysis
7.9.2. Asia Pacific Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.3. China
7.9.3.1. Key Country Dynamics
7.9.3.2. Target Disease Prevalence
7.9.3.3. Competitive Scenario
7.9.3.4. Regulatory Framework
7.9.3.5. China Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.4. Japan
7.9.4.1. Key Country Dynamics
7.9.4.2. Target Disease Prevalence
7.9.4.3. Competitive Scenario
7.9.4.4. Regulatory Framework
7.9.4.5. Japan Market estimates and forecast, 2018 – 2030 (Volume, Thousand)
7.9.5. India
7.9.5.1. Key Country Dynamics
7.9.5.2. Target Disease Prevalence
7.9.5.3. Competitive Scenario
7.9.5.4. Regulatory Framework
7.9.5.5. India Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.6. Australia
7.9.6.1. Key Country Dynamics
7.9.6.2. Target Disease Prevalence
7.9.6.3. Competitive Scenario
7.9.6.4. Regulatory Framework
7.9.6.5. Australia Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.7. Thailand
7.9.7.1. Key Country Dynamics
7.9.7.2. Target Disease Prevalence
7.9.7.3. Competitive Scenario
7.9.7.4. Regulatory Framework
7.9.7.5. Thailand Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.9.8. South Korea
7.9.8.1. Key Country Dynamics
7.9.8.2. Target Disease Prevalence
7.9.8.3. Competitive Scenario
7.9.8.4. Regulatory Framework
7.9.8.5. South Korea Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.10. Latin America
7.10.1. SWOT Analysis
7.10.2. Latin America Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.10.3. Brazil
7.10.3.1. Key Country Dynamics
7.10.3.2. Target Disease Prevalence
7.10.3.3. Competitive Scenario
7.10.3.4. Regulatory Framework
7.10.3.5. Brazil Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.10.4. Mexico
7.10.4.1. Key Country Dynamics
7.10.4.2. Target Disease Prevalence
7.10.4.3. Competitive Scenario
7.10.4.4. Regulatory Framework
7.10.4.5. Mexico Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.10.5. Argentina
7.10.5.1. Key Country Dynamics
7.10.5.2. Target Disease Prevalence
7.10.5.3. Competitive Scenario
7.10.5.4. Regulatory Framework
7.10.5.5. Argentina Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.11. MEA
7.11.1. SWOT Analysis
7.11.2. MEA Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.11.3. Saudi Arabia
7.11.3.1. Key Country Dynamics
7.11.3.2. Target Disease Prevalence
7.11.3.3. Competitive Scenario
7.11.3.4. Regulatory Framework
7.11.3.5. Saudi Arabia Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.11.4. South Africa
7.11.4.1. Key Country Dynamics
7.11.4.2. Target Disease Prevalence
7.11.4.3. Competitive Scenario
7.11.4.4. Regulatory Framework
7.11.4.5. South Africa Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.11.5. UAE
7.11.5.1. Key Country Dynamics
7.11.5.2. Target Disease Prevalence
7.11.5.3. Competitive Scenario
7.11.5.4. Regulatory Framework
7.11.5.5. UAE Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
7.11.6. Kuwait
7.11.6.1. Key Country Dynamics
7.11.6.2. Target Disease Prevalence
7.11.6.3. Competitive Scenario
7.11.6.4. Regulatory Framework
7.11.6.5. Kuwait Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. ECKERT & ZIEGLER BEBIG
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. ISORAY MEDICAL, INC.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. ELEKTA AB
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. THERAGENICS
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Becton, Dickinson, and Company
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. CIVCO MEDICAL SOLUTIONS
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. SUN NUCLEAR CORPORATION
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. ICAD, INC.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. VARIAN MEDICAL SYSTEMS, INC.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 3 North America brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 4 North America brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 5 North America brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 7 U.S. brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 9 Canada brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 10 Canada brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 11 Canada brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 12 Europe brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 13 Europe brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 14 Europe brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 15 Europe brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 16 Germany brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 17 Germany brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 18 Germany brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 19 UK brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 20 UK brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 21 UK brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 22 France brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 23 France brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 24 France brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 25 Italy brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 26 Italy brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 27 Italy brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 28 Spain brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 29 Spain brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 30 Spain brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 31 Denmark brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 32 Denmark brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 33 Denmark brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 34 Sweden brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 35 Sweden brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 36 Sweden brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 37 Norway brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 38 Norway brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 39 Norway brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 40 Asia Pacific brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 43 Asia Pacific brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 44 China brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 45 China brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 46 China brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 47 Japan brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 48 Japan brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 49 Japan brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 50 India brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 51 India brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 52 India brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 53 South Korea brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 54 South Korea brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 55 South Korea brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 56 Australia brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 57 Australia brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 58 Australia brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 59 Thailand brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 60 Thailand brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 61 Thailand brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 62 Latin America brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 63 Latin America brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 64 Latin America brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 67 Brazil brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 68 Brazil brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 69 Mexico brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 70 Mexico brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 71 Mexico brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 72 Argentina brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 73 Argentina brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 74 Argentina brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa brachytherapy market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 80 South Africa brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 81 South Africa brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 85 UAE brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 86 UAE brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 87 UAE brachytherapy market, by application, 2018 - 2030 (USD Million)
Table 88 Kuwait brachytherapy market, by dosage type, 2018 - 2030 (USD Million)
Table 89 Kuwait brachytherapy market, by product, 2018 - 2030 (USD Million)
Table 90 Kuwait brachytherapy market, by application, 2018 - 2030 (USD Million)

★調査レポート[近接照射療法の世界市場2023-2030：市場規模、シェア、動向分析] (コード：GRV23OCT057)販売に関する免責事項を必ずご確認ください。
★調査レポート[近接照射療法の世界市場2023-2030：市場規模、シェア、動向分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 鎌状赤血球症治療の世界市場2023-2030：市場規模、シェア、動向分析
  • 鎌状赤血球症治療の世界市場2023-2030：市場規模、シェア、動向分析
  • ガラス化の世界市場2023-2030：市場規模、シェア、動向分析
  • ガラス化の世界市場2023-2030：市場規模、シェア、動向分析
  • 着床前遺伝子検査（PGT）の世界市場2023-2030：市場規模、シェア、動向分析
  • 着床前遺伝子検査（PGT）の世界市場2023-2030：市場規模、シェア、動向分析
  • 血液検査の世界市場2023-2030：市場規模、シェア、動向分析
  • 血液検査の世界市場2023-2030：市場規模、シェア、動向分析
  • ナルコレプシー治療薬の世界市場2023-2030：市場規模、シェア、動向分析
  • ナルコレプシー治療の世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆